- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05535296
Prevention of Lifestyle-related Ill-health With Early Functional Examinations and Individualized Risk Profiles (PREVFUNKTION)
Prevention of Lifestyle-related Ill-health With Early Examinations of Health and Function and Individualized Risk Profiles (PREFUNKTION), a Pilot Study.
Background: Many lifestyle-related health disorders are influenced by physical activity level and physical function. Health examinations which focus on musculoskeletal function of people who have risk factors for lifestyle-related disorders, combined with person-centered advice based on risk profiles can give people knowledge and guidance to manage their own lifestyle priorities.
Aim: To investigate the feasibility of a protocol for a randomized controlled trial (RCT) which will examine the preventive effects of musculoskeletal function examinations and person-centered advice on inactive middle-aged people.
Methods: Physically inactive middle-aged people will be invited to participate in a two-part health examination with follow-up after three months in a pilot study. Part 1 is a standard health examination including blood tests and Part 2 is a functional examination of fitness, strength, mobility, balance and posture according to our protocol based on validated tests. The intervention group receives feedback based on both parts of the examination while the control group receives feedback only from Part 1. Physical activity level will be measured objectively with accelerometers at inclusion and follow-up.
Expected results: The pilot study is expected to show whether the planned RCT is practically feasible and to give relevant support for the power analysis for a later full-scale RCT. Better understanding of personal physical function and risk factors can facilitate lifestyle decisions on the individual level which can reduce the risk for later ill-health and need of health-care. Preventive interventions may contribute to reduce the ever-increasing level of lifestyle-related ill-health.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gothenburg, Sweden, 418 33
- Närhälsan Biskopsgården Health centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Born 1982 (aged 40 years). Self-assessed as physically inactive. Self-reported normal general mobility - can walk without support and has full use of all 4 extremities.
Exclusion Criteria:
- Self-reported regular moderate-to-intensive physical activity more than once per week. Pregnancy. Ongoing treatment requiring hospital-based services. Severe mental illness or intellectual impairment. Need of interpreter to participate in the study or answer the questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Standard health examination and related feedback.
Functional examination.
Risk profile and related advice.
|
Compiliation of risk profile based on fitness, strength, mobility, balance, posture, physical activity level, weight and pain.
Advice based on the above and support in goal-setting.
|
|
No Intervention: Control group
Standard health examination and related feedback.
Functional examination.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity level
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Mean number of daily minutes in moderate-to-intensive physical activity measured with accelerometers during one week.
|
Change between inclusion and 3-4 month follow-up.
|
|
Participant feedback
Time Frame: Measured at 3-4 month follow-up.
|
Rating of overall helpfulness of intervention in intervention group on 0 to 5 numerical rating scale ranging between 0=No help at all and 5=Very helpful.
|
Measured at 3-4 month follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant feedback functional tests-Borg inclusion
Time Frame: Measured at inclusion.
|
Rating of difficulty of individual functional tests on the Borg Rating of Perceived Exertion scale, ranging from 6 to 20 with higher levels indicating higher exertion level.
|
Measured at inclusion.
|
|
Participant feedback functional tests-Borg follow-up
Time Frame: Measured at 3-4 month follow-up.
|
Rating of difficulty of individual functional tests on the Borg Rating of Perceived Exertion scale, ranging from 6 to 20 with higher levels indicating higher exertion level.
|
Measured at 3-4 month follow-up.
|
|
Participant feedback functional tests-instructions
Time Frame: Measured at inclusion.
|
Rating of how understandable the instructions were on a 0 to 5 numerical rating scale where 0 is completely ununderstandable and 5 is very easy to understand.
|
Measured at inclusion.
|
|
Participant feedback - descriptive inclusion
Time Frame: Recorded at inclusion.
|
Voluntary subjective impressions of the intervention
|
Recorded at inclusion.
|
|
Participant feedback - descriptive follow-up
Time Frame: Recorded at 3-4 month follow-up.
|
Voluntary subjective impressions of the intervention
|
Recorded at 3-4 month follow-up.
|
|
Risk levels
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Change in risk levels on the risk profile.
|
Change between inclusion and 3-4 month follow-up.
|
|
Goal achievement
Time Frame: 3-4 month follow-up
|
Proportion of goals set at inclusion achieved.
|
3-4 month follow-up
|
|
Ekblom-Bak fitness test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured as VO2-max in ml/kg/min where higher values indicate better fitness level.
|
Change between inclusion and 3-4 month follow-up.
|
|
2-minute step test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with number of steps, where higher values indicate better fitness level.
|
Change between inclusion and 3-4 month follow-up.
|
|
Body mass index
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Calculated by weight in kg divided by squared height in meters.
|
Change between inclusion and 3-4 month follow-up.
|
|
Waist circumference
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured in centimeters with measuring tape.
|
Change between inclusion and 3-4 month follow-up.
|
|
Handgrip strength
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with Jamar dynamometer, with higher numbers indicating greater strength.
|
Change between inclusion and 3-4 month follow-up.
|
|
30-second biceps test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured by maximum number of repetitions with 2 kg (women) or 4 kg (men) dumbbell during 30 seconds, with higher numbers indicating greater strength.
|
Change between inclusion and 3-4 month follow-up.
|
|
Unilateral heel rise test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum number of repetitions per leg, with higher numbers indicating greater strength.
|
Change between inclusion and 3-4 month follow-up.
|
|
30-second chair stand test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum number of repetitions during 30 seconds, with higher numbers indicating greater strength.
|
Change between inclusion and 3-4 month follow-up.
|
|
Plank test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum endurance time, with longer time indicating better trunk strength.
|
Change between inclusion and 3-4 month follow-up.
|
|
Sorenson's back extension test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum endurance time, with longer time indicating better trunk strength.
|
Change between inclusion and 3-4 month follow-up.
|
|
Supine bridge test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum endurance time, with longer time indicating better trunk strength.
|
Change between inclusion and 3-4 month follow-up.
|
|
Stand-on-one-leg eyes-open test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum endurance time, with higher numbers indicating better balance.
|
Change between inclusion and 3-4 month follow-up.
|
|
Stand-on-one-leg eyes-closed test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum endurance time, with higher numbers indicating better balance.
|
Change between inclusion and 3-4 month follow-up.
|
|
Sharpened Romberg
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with maximum endurance time, with higher numbers indicating better balance.
|
Change between inclusion and 3-4 month follow-up.
|
|
Functional Reach test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with reach limit in centimeters, with higher numbers indicating better balance.
|
Change between inclusion and 3-4 month follow-up.
|
|
Lateral Reach test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with reach limit in centimeters, with higher numbers indicating better balance.
|
Change between inclusion and 3-4 month follow-up.
|
|
Navicular Drop test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured as drop distance in millimeters, with higher numbers indicating higher dgree of pronation.
|
Change between inclusion and 3-4 month follow-up.
|
|
Occiput-to-wall test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured as contact or no contact between head and wall.
|
Change between inclusion and 3-4 month follow-up.
|
|
Patella mobility
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured as locked or not locked patella in habitual standing position.
|
Change between inclusion and 3-4 month follow-up.
|
|
Sit-rise test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured as points on 0-10 scale, with higher numbers indicating better mobility.
|
Change between inclusion and 3-4 month follow-up.
|
|
Fingertip-floor test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured as distance in centimeters, with higher numbers indicating lower mobility.
|
Change between inclusion and 3-4 month follow-up.
|
|
Lateral flexion test
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured as distance in millimeters, with higher numbers indicating better mobility.
|
Change between inclusion and 3-4 month follow-up.
|
|
Beighton's hypermobility score
Time Frame: Measured at inclusion.
|
Measured on 0 to 9 scale with higher numbers indicating higher level of hypermobility
|
Measured at inclusion.
|
|
Number of pain locations
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Change in number of pain locations on pain diagram.
|
Change between inclusion and 3-4 month follow-up.
|
|
Health-related quality of life
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with Euroqol-5 dimensions, 5 questions and 0-100 barometer.
Higher scores indicate better quality of life.
|
Change between inclusion and 3-4 month follow-up.
|
|
Self-reported physical activity_SGPALS
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with Saltin-Grimby Physical Activity Level Scale (0 to 4 descriptive levels).
Higher levels indicate more physically active.
|
Change between inclusion and 3-4 month follow-up.
|
|
Self-reported physical activity_SNBHW
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with the Swedish National Board of Health and Welfare's 2 questions on physical activity (choose from 6 descriptive levels of exercise and 7 descriptive levels of daily activity).
Higher levels indicate more physically active.
|
Change between inclusion and 3-4 month follow-up.
|
|
Sedentary time
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with the SED-GIH question on time sitting still (7 levels from almost always to never).
Higher levels indicate more physically active.
|
Change between inclusion and 3-4 month follow-up.
|
|
Risk for developing long-term musculoskeletal disorders
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Measured with the Örebro Musculoskeletal Pain Screening Questionnaire (10 questions, max 100 points, higher values indicate increased risk for longterm pain.
|
Change between inclusion and 3-4 month follow-up.
|
|
Blood pressure
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Change in blood pressure.
|
Change between inclusion and 3-4 month follow-up.
|
|
Blood tests
Time Frame: Change between inclusion and 3-4 month follow-up.
|
Whether or not acceptable levels of serum cholesterol (3.3 to 6.9mmol/L), triglycerides (0.45 to 2.6 mmol/L), LDL-cholesterol (1.4 to 4.7 mmol/L), HDL cholesterol (women 1.0 to 2.7 and men 0.80 to 2.1 mmol/L) and blood glucose (4.0 to 6.0 mmol/L).
|
Change between inclusion and 3-4 month follow-up.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lena Bornhöft, PhD, Region Västra Götaland, University of Gothenburg
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- VGFOUREG-968488
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lifestyle Risk Reduction
-
Eindhoven University of TechnologyCompletedLifestyle | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, SedentaryBelgium
-
KAGOME CO., LTD.Dr. Binh_Teleclinic - Branch of E2E Solution Company LimitedCompleted
-
Università degli Studi del Piemonte Orientale "Amedeo...UnknownLifestyle Risk ReductionItaly
-
Colorado State UniversityUniversity of Colorado, Denver; United States Department of Agriculture (USDA) and other collaboratorsRecruitingMental Health Wellness | Lifestyle Risk Reduction | Family ResearchUnited States
-
National Taiwan University HospitalCompletedLifestyle Risk Reduction | Elderly Adults | Community DwellingTaiwan
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University of CopenhagenTechnical University of DenmarkCompleted
-
Hadassah Medical OrganizationEnrolling by invitationCardiovascular Diseases | Lifestyle Risk ReductionIsrael
-
Arkansas Heart HospitalCompletedCardiovascular Diseases | Lifestyle Risk ReductionUnited States
-
University of California, San FranciscoKorean Community Center of the East BayCompletedSmoking Cessation | Lifestyle Risk ReductionUnited States
Clinical Trials on Risk profile
-
University Hospital, AntwerpKarolinska University Hospital; Karolinska Institutet; Rigshospitalet, Denmark; Heinrich-Heine University, Duesseldorf and other collaboratorsNot yet recruitingBarrett Esophagus | Gastroenterology | Barrett Esophagus Adenocarcinoma | Adenocarcinoma - GEJ | Gastroenterological CancerDenmark, Belgium, Sweden, Ireland, Italy, France, Germany
-
McGill UniversityPfizerCompletedHypertension | Obesity | Diabetes | Sedentary Lifestyle | Dyslipidemia | Cigarette SmokingCanada
-
Azienda Ospedaliero-Universitaria di ModenaAzienda Ospedaliero-Universitaria Careggi; University of Modena and Reggio... and other collaboratorsRecruiting
-
Berceste GulerCompletedPeri-Implantitis | Peri-implant Mucositis | Dental Implant FailedTurkey
-
Riyadh Colleges of Dentistry and PharmacyCompletedCerebral Palsy | Dental DiseasesSaudi Arabia
-
Universidad Peruana Cayetano HerediaInter-American Development BankCompletedQuality of Health Care
-
Philipps University Marburg Medical CenterCompletedDiabetes Mellitus Type 2Germany
-
University Hospital, BordeauxRecruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruitingBreast Cancer | Ovarian Cancer | Colon Cancer | Genetic Risk FactorsItaly
-
University of SalamancaCompletedBone Loss | Dental Implant | Partial-edentulism | Soft TissueSpain